Skip to main content
Guidance

Pesticide changes for manufacturers

An overview of changes to how pesticides will be regulated in Great Britain following the UK-EU SPS agreement.

The UK and EU have agreed to align on sanitary and phytosanitary (SPS) rules, from 1 March 2028. This will affect rules for food and feed, plants, animals and other agrifood goods.

Find out more about the agreement and its impact.

Who should read this guidance

This guidance is relevant to all businesses involved in the manufacturing, processing, distribution and supply of PPPs, including:

  • active substance producers
  • PPP authorisation holders
  • PPP marketing companies
  • PPP manufacturers and processors
  • PPP importers and exporters
  • PPP distributors and wholesalers
  • PPP suppliers and retailers

Legislation will be required to make detailed changes to implement the SPS Agreement and to support alignment. It will be published when it is laid before parliament.

We intend to share draft versions of the legislation before this and will communicate the details of the changes it will enact as work progresses.

Businesses should closely review the new legislation and guidance that applies to their activities, once that legislation and guidance becomes available.

Overview of changes

From 1 March 2028, the EU regulations governing PPPs and MRLs will apply in Great Britain. The current equivalent Great Britain regulations will be repealed.

HSE will carry out a check of existing Great Britain PPP authorisations against the applicable EU requirements specified under the agreement, rather than a full reassessment against all the requirements that would apply to a new EU PPP authorisation.

This check will ensure that Great Britain PPP authorisations satisfy the following requirements in Regulation (EC) No 1107/2009:

  • Article 29(1) (a) to (d)

  • Article 29(1) (f) to (i)

  • Article 4(3), in light of the scientific and technical knowledge available at the time when the GB authorisation was granted

The check will also ensure that Great Britain PPP authorisations comply with any specific conditions and restrictions applicable to the relevant EU active substance approval.

HSE will begin work before the application date to undertake these checks. Where the existing authorisations satisfy the relevant requirements, they will simply remain in place (category 4 below).

Where the existing authorisations do not satisfy the relevant requirements, action will be taken in accordance with the applicable transitional arrangements described under categories 1 to 3 below. Further information will be provided in due course on the timing and operation of these pre-application date measures, including any action required of duty holders.

Transitional arrangements will give businesses time to adapt and manage affected stocks and goods already on the market, while government makes the necessary changes to the regulatory system.

After the application date of the agreement, companies will also be able to apply for Great Britain authorisations for PPPs containing active substances that are approved in the EU but not currently approved in Great Britain.

Separate amendments or withdrawals may still take effect before application date for reasons unrelated to the SPS transition, for example, for consumer safety reasons or where an authorisation was already due to expire in Great Britain.

Implications for businesses

The agreement affects different PPPs, and different businesses, in different ways. For businesses, the key question will be whether an existing Great Britain PPP authorisation:

  • continues unchanged

  • requires action to amend it, or

  • needs to be withdrawn

PPPs are grouped into four categories, set out below. We will share more detailed information on the specific active substances and products where there will be changes, including which category they fall into, in due course.

  1. Category 1: PPPs containing one of the active substances, cinmethylin, pydiflumetofen and isoflucypram which are already approved in Great Britain and awaiting an EU decision will remain on the GB market until the EU has reached a decision.

  2. Category 2: PPPs containing active substances approved in Great Britain but not approved in the EU (other than the category 1 cases), where GB authorisations will be withdrawn.

  3. Category 3: PPPs containing EU-approved active substances where the existing GB authorisation requires amendment or withdrawal following the check.

  4. Category 4: PPPs where authorisations satisfy HSE’s check.

The remainder of this guidance discusses how each category is treated and what actions businesses may need to take. EU rules and regulatory approvals may change between now and application date.

A PPP authorisation may be affected where, for instance:

  • the active substance it contains is not approved in the EU

  • the existing Great Britain authorisation permits a use that is prohibited by restrictions on the relevant EU active substance approval

  • an authorised use, including a use authorised under EAMU (Extension of Authorisation for Minor Use), would result in treated commodities exceeding the applicable EU MRL

  • the existing Great Britain authorisation permits a use that results in residues in the treated crops that will not comply with the EU MRLs in force

Applications, renewals and assessments already underway

You should be aware that after the application date, HSE will no longer process active substance and MRL applications for Great Britain, and applications for PPPs will need to be admissible under the EU regulatory framework. Applicants should take this into account when considering future applications and progressing existing applications.

We are considering the appropriate handling of new and ongoing applications as Great Britain transitions towards the SPS Agreement taking effect.

Options being considered include amending or stopping work on Great Britain applications that may not be compatible with the EU pesticides regime, and accepting applications compatible with the EU regime before the application date.

We are also considering how to give timely effect to the required checking and other actions needed for existing authorisations and approvals. This includes considering action being taken in advance of the application date of the SPS Agreement.

Details remain subject to legislative and operational processes.

Regulatory treatment of plant protection products

Category 1: PPPs containing one of the active substances, cinmethylin, pydiflumetofen and isoflucypram which are already approved in Great Britain and awaiting an EU decision will remain on the Great Britain market until the EU has reached a decision

Businesses manufacturing, marketing or using PPPs containing one of the three new active substances that are currently approved in Great Britain but awaiting EU decision: cinmethylin, isoflucypram and pydiflumetofen, may continue to market them in Great Britain under existing Great Britain authorisations while the EU active substance approval decision is pending.

Great Britain MRLs for these three active substances will also be retained while the relevant EU decisions are pending. Treated produce intended for the EU market must comply with the applicable EU MRLs.

If the EU approves these substances, relevant Great Britain PPP authorisations will be checked against the applicable EU requirements specified under the agreement to determine whether their authorisations can be retained as they are, need amendment, or must be withdrawn - within 3 months of the EU approval decision coming into force.

Where amendment or withdrawal is required, the category 3 transitional arrangements will apply, with relevant transitional arrangements commencing from the date the EU approval decision comes into force.

If the EU makes a non-approval decision on these substances after application date, affected PPP authorisations will be withdrawn within 3 months of the date of that decision coming into force.

Sale of these PPPs in Great Britain must cease within 3 months of the EU decision and final use and safe disposal within 9 months of the decision. If the EU makes such decision prior to the application date, the PPP authorisation will be subject to the same transitional arrangements as those PPPs in category 2, with relevant transitional arrangements commencing from the date the EU non-approval decision comes into force.

Before the relevant Great Britain legislation is in place to implement and transition to the agreement, existing regulations will continue to apply.

EU rules and regulatory approvals may change between now and application date. Businesses can consult the list of EU active substance approvals.

Category 2: PPPs containing active substances approved in Great Britain but not approved in the EU (other than category 1 cases), where GB authorisations will be withdrawn

Authorisations for products containing active substances not approved in the EU at application date will be withdrawn, subject to the applicable transitional arrangements, set out below. This does not include the three new active substances if, at that date, they are still awaiting an EU decision (which are in category 1).

Annex 1 provides details of the relevant active substances identified as approved in Great Britain but not approved in the EU for reference.

Transitional arrangements provide the timeline for such PPPs to be withdrawn from use. Category 2 authorisations may still be:

  • placed on the market (including sale, supply and distribution) for up to 3 months after application date
  • used, stored, and disposed of for up to 9 months after application date

Read the list of Great Britain active substance approvals.

Read the list of EU active substance approvals.

Crops treated with PPPs that fall into this category during these transitional arrangements may continue to be harvested and placed on the market, as set out in the MRL compliance section below.

HSE check

HSE will undertake a check of all existing Great Britain PPP authorisations, where the active substance is authorised in Great Britain and the EU, against the relevant EU law requirements to determine whether an authorisation can continue unchanged or requires action. Further detail on the checks is within the relevant sections below.

Depending on the outcome of the check, an existing Great Britain PPP authorisation may continue unchanged or may require amendment or withdrawal. Further information will be provided on this process.

Category 3: PPPs containing EU-approved active substances where the existing Great Britain authorisation requires amendment or withdrawal following the check

These products contain active substances approved in the EU, but the existing Great Britain PPP authorisation requires amendment or withdrawal following HSE’s check.

This may be because the existing Great Britain authorisation permits a use that is prohibited by restrictions on the relevant EU active substance approval, the product contains a co-formulant prohibited under the EU regulatory framework, or current Great Britain uses would result in treated produce that does not comply with applicable EU MRLs.

n these cases, the relevant PPP authorisations will either need to be withdrawn or amended in order to become compliant with EU requirements (for example, to include new label conditions or restrictions).

If PPPs are deemed to need amendment to be compliant then authorisation holders will be contacted by HSE, proposing action that could be taken and the framework under which this is being implemented.

HSE will undertake the check using information it already holds alongside relevant information from EU systems and databases; authorisation holders will not be required to demonstrate compliance themselves as part of the initial check, although HSE may request further information where necessary.

Businesses should note that even if the initial indications are that the authorisation will pass the check, this will be subject to any further EU changes before application date. Therefore, final compatibility cannot be confirmed until after the application date.

If PPPs must be withdrawn, affected PPPs may still be bought, used, stored or disposed of during the relevant transitional arrangements:

  • placed on the market (including sale, supply and distribution) for up to 9 months after application date
  • used, stored and disposed of for up to 21 months after application date

To understand what you are able to place on the market and MRL compliance, read the MRLs section.

Category 4: PPPs where authorisations satisfy HSE’s check

These PPPs will be recognised as satisfying EU requirements and their authorisations do not need to be changed. Businesses should continue with normal production, marketing or use and follow any existing label requirements.

However, EU Member States will not be able to recognise Great Britain authorisations granted prior to application date under the mutual recognition provisions of the EU regulations.

Great Britain authorisations granted after application date may be eligible for mutual parallel recognition under the applicable EU rules.

  • no transitional arrangements will apply to these PPPs, as no changes will take effect
  • businesses must continue to comply with the applicable authorisation, label and other regulatory requirements

EU-approved active substances not currently approved in Great Britain

There are some active substances which are not currently approved in Great Britain, but which have been approved in the EU already.

Once the agreement has been applied, there will be the opportunity for businesses to apply for Great Britain authorisations for PPPs containing these active substances.

Further information outlining how the regulatory system will function, including how applications for new PPPs can be submitted to HSE, will be available in due course.

Maximum residue levels (MRLs)

As part of the check, HSE will consider whether existing PPP authorisations will be affected by alignment with EU MRLs.

If an authorisation requires amendment or withdrawal, HSE will contact the approval holder to set out next steps. Where amendment or withdrawal are required, the transitional arrangements set out for category 3 PPPs will apply.

After the application date, MRLs will be set and amended in line with EU decisions under the aligned framework. The accompanying food and feed businesses guidance explains what MRL alignment and transitional arrangements mean for food and feed businesses and treated produce.

Read more information on MRLs from HSE.

Read the current GB MRL Statutory Register from HSE.

Read information on EU MRLs from the European Commission.

What remains the same

Food and feed products which were placed on the market before the application date may continue to be placed on the GB market where they meet the GB MRL that applied immediately before the application date.

Food and feed products which were produced using a PPP whose authorisations were amended or withdrawn, including plant protection products containing pydiflumetofen, cinmethylin or isoflucypram, may continue to be placed on the GB market where they meet the GB MRL that applied immediately before the application date.  

Post-agreement application date, emergency authorisations will continue to be available. For more information on emergency authorisations refer to HSE guidance on emergency authorisation.

Post-agreement application date, EAMUs will continue to be available under the EU regulations.

Other regulatory mechanisms

Treated seeds

Temporary arrangements are currently in place to allow the use of EU treated seed in Great Britain. These arrangements end on 1 July 2027. Until then, farmers and growers may continue to use EU treated seed where it is covered by those temporary arrangements and any applicable conditions are met.

After 1 July 2027, and until application date, only treated seed approved for use in Great Britain can be used. Farmers, growers and agronomists should check the status of treated seed with suppliers before purchase and use, particularly when planning for the 2028 season.

Further information will be provided if these arrangements change.

After the application date, EU treated seed rules will apply.

Parallel trade

Parallel Trade is part of the EU regime that Great Britain will be aligning with, so Great Britain will once again have access to this. Further information on how to access the parallel trade scheme will be provided in due course.

Mutual recognition

After application date, Great Britain will be able to participate in the EU regime’s Mutual Recognition processes. This will assist in providing access to additional PPPs that are already authorised in other EU Member States. Further information on how to access the mutual recognition scheme, once in place, will be provided in due course.

What this means for Northern Ireland

The Common SPS Area does not change the rules on PPPs, PPP active substances or MRLs that already apply in Northern Ireland.

Under the Windsor Framework, EU PPPs rules already apply in Northern Ireland. The Common SPS Area means that Great Britain will align with those rules from 1 March 2028, so that the same rules on PPPs, active substances and MRLs will apply across Great Britain and Northern Ireland. This should simplify supply to both markets and support product availability in Northern Ireland.

Transitional arrangements will apply to enable the movement of eligible relevant foods from Great Britain to Northern Ireland in line with the transitions negotiated under the SPS Agreement for PPPs. Further details will be shared on these arrangements to ensure that traders and individuals have the necessary time to prepare.

From the application date of the SPS Agreement, PPPs with an existing Great Britain authorisation may continue to be placed on the Great Britain market subject to the applicable transitional arrangements. These PPPs must not be moved to Northern Ireland or the EU.

Only PPPs with the appropriate authorisation may be placed on the market in Northern Ireland or the EU. Businesses must ensure appropriate controls are in place to distinguish between goods compliant for Great Britain transitional arrangements and those compliant with EU requirements.

Enforcement in Northern Ireland is carried out by the relevant bodies in line with EU SPS legislation as applied under the Windsor Framework.

The existing unfettered market access arrangements for qualifying goods moving from Northern Ireland to Great Britain will continue to apply.

What do I need to do

Summary of actions for businesses

Businesses may wish to perform an initial assessment of which transition category applies to their PPPs, including:

  • non-EU approved active substances (categories 1 and 2)
  • PPPs containing EU-approved active substances where the existing authorisation requires regulatory action following the check (category 3)
  • MRL-driven changes to authorisations which might lead to a PPP being non-compliant (category 3)
  • EU-compliant PPP authorisations with no changes required (category 4)
  • non-EU approved active substances (categories 1 and 2)
  • EU-approved active substances requiring regulatory action (category 3)
  • MRL-driven changes to authorisations (category 3)
  • EU-compliant active substances with no changes required   (category 4)

Further information will be provided in due course regarding the specific implementation mechanisms for making the changes laid out in this document. Importantly, this includes HSE’s check, following which it will communicate any actions required of duty holders. Businesses must ensure systems are in place to maintain traceability, manage compliance with transition timelines, and clearly distinguish between products placed under Great Britain transitional arrangements and those destined for the EU market.

PPP manufacturers and authorisation holders

Manufacturers, authorisation holders and marketing companies will be responsible for ensuring that PPPs placed on the market continue to comply with the requirements that apply under the SPS Agreement from application date, as well as any pre-application date measures advised by HSE.

Authorisation holders should:

  • start to consider which arrangements need to be in place to manage compliance with the transitional arrangements
  • monitor further information on the timing and operation of these pre-application date measures
  • take any action required to enable compliance

PPP suppliers and distributors

Suppliers and distributors play a key role in ensuring that products are correctly managed through the supply chain during the transitional arrangements, including ensuring that only compliant products are supplied into appropriate markets. We will continue to publish information and guidance as we move towards application date to ensure that these businesses have the information they need to do this.

Suppliers and distributors should:

  • keep track of changes to Great Britain product authorisations, including withdrawals, over the transition
  • manage stock in line with transition timelines

Enforcement is undertaken by relevant competent authorities, including HSE and local authorities, in line with statutory roles. Read HSE guidance on what to expect from an official controls visit in England, Scotland and Wales.

Managing transitional stock

Businesses should link affected batches to the relevant regulatory decision and transition deadlines. Records and stock controls should distinguish products subject to different authorisations conditions or market restrictions.

Businesses involved in both PPP traceability and MRL requirements (food or feed containing pesticide residues) activities should link the records where relevant but should not treat PPP traceability records as proof of MRL compliance or apply the PPP five-year retention requirement indiscriminately to food and feed records.

Support, guidance and further information

Businesses should continue to follow existing requirements unless notified otherwise and monitor updates and guidance from:

There may be aspects of an authorisation or inflight application that require amendment or additional information should an authorisation holder wish to support a compatible product post-application. HSE can advise what steps could be taken.

Annex 1: active substances identified as approved in Great Britain but not approved in the EU

Important: We have compiled this list of active substances approved in Great Britain but not approved in the EU using the HSE’s list of GB active substance approvals and the European Commission’s list of EU active substance approvals.

This represents our best understanding of the correct data at the time of publication on 20 November 2026. Before taking any action or relying on this list, you should consult the HSE’s list of GB active substance approvals and the European Commission’s list of EU active substance approvals for the most up-to-date and accurate information.

Further information on the implications for GB-authorised products will be provided in due course.

Active substance Number of GB PPPs
Isopyrazam 10
Bacillus firmus I-1582 1
Prochloraz 6
Benfluralin 0
Benthiavalicarb 2
Dimethomorph 14
Flufenacet 147
Ipconazole 3
Clofentezine 2
Dimoxystrobin 2
Metribuzin 23
S-Metolachlor 6
Triflusulfuron-methyl 11
Metiram 0
Mepanipyrim 1
Spirotetramat 3
Acibenzolar-S-methyl (benzothiadiazole) 0
Penthiopyrad 8
(E,Z)-8-Dodecen-1-yl acetate 0
(E,Z)-9-Dodecen-1-yl acetate 0
Acrinathrin 0
Methyl decanoate (CAS 110-42-9) 0
Methyl octanoate (CAS 111-11-5) 0
Oleic acid (CAS 112-80-1) 0

Stay informed

Find out what support will be available for businesses and sign up for updates and emails.

Sign up for emails or print this page